Antiretroviral therapy in macrophages: implication for HIV eradication. - sprookjes - yvandenbroek - TriplyDB

Antiretroviral therapy in macrophages: implication for HIV eradication.

Antiretroviral therapy in macrophages: implication for HIV eradication.

http://www.wikidata.org/entity/Q34298792

about

Eradication of HIV from the brain: reasons for pause The macrophage: a therapeutic target in HIV-1 infection Gastrointestinal tract and the mucosal macrophage reservoir in HIV infection Targeting the Brain Reservoirs: Toward an HIV Cure HIV-1 infection and first line ART induced differential responses in mitochondria from blood lymphocytes and monocytes: the ANRS EP45 "Aging" study Single-domain antibody-SH3 fusions for efficient neutralization of HIV-1 Nef functions High-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse.Ruxolitinib and tofacitinib are potent and selective inhibitors of HIV-1 replication and virus reactivation in vitro.Viral decay kinetics in the highly active antiretroviral therapy-treated rhesus macaque model of AIDS.Alcohol consumption effect on antiretroviral therapy and HIV-1 pathogenesis: role of cytochrome P450 isozymes.Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS Analysis of multiply spliced transcripts in lymphoid tissue reservoirs of rhesus macaques infected with RT-SHIV during HAART Role of myeloid cells in HIV-1-host interplay.Alterations in P-Glycoprotein Expression and Function Between Macrophage Subsets.Preparation, characterization, and safety evaluation of poly(lactide-co-glycolide) nanoparticles for protein delivery into macrophages.HIV-1 induces telomerase activity in monocyte-derived macrophages, possibly safeguarding one of its reservoirs.Inhibition of HIV Expression and Integration in Macrophages by Methylglyoxal-Bis-Guanylhydrazone.Practical Considerations For Developing Nucleoside Reverse Transcriptase Inhibitors.HIV-1 and the immune response to TB.The meningeal lymphatic system: a route for HIV brain migration?Overcoming pharmacologic sanctuaries.Anti-HIV host factor SAMHD1 regulates viral sensitivity to nucleoside reverse transcriptase inhibitors via modulation of cellular deoxyribonucleoside triphosphate (dNTP) levels.Antiretroviral monocyte efficacy score linked to cognitive impairment in HIV.Strategies to target non-T-cell HIV reservoirs Diverse fates of uracilated HIV-1 DNA during infection of myeloid lineage cells.Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosis HIV Maintains an Evolving and Dispersed Population in Multiple Tissues during Suppressive Combined Antiretroviral Therapy in Individuals with Cancer.Potential strategies for an HIV infection cure.HIV-associated neurological disorders: a guide to pharmacotherapy.Understanding HIV compartments and reservoirs.Landscape review of current HIV 'kick and kill' cure research - some kicking, not enough killing.Eradication of HIV from Tissue Reservoirs: Challenges for the Cure.Lipopolysaccharide suppresses human immunodeficiency virus 1 reverse transcription in macrophages.Genetic Polymorphisms Affecting the Pharmacokinetics of Antiretroviral Drugs.The HIV-1 Vpr Protein: A Multifaceted Target for Therapeutic Intervention.Mechanisms of HIV persistence in HIV reservoirs.The Role of HIV Infection in Neurologic Injury.HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy.Interleukin 1-Beta (IL-1β) Production by Innate Cells Following TLR Stimulation Correlates With TB Recurrence in ART-Treated HIV-Infected Patients.Cellular pharmacology and potency of HIV-1 nucleoside analogs in primary human macrophages.

P2860

Q24612874-C2583CD1-4485-43FC-A0AE-04F84681BD94 Q26823236-EF89AE31-F655-4A6A-A8C7-083EFF681C89 Q26850379-DF361764-E9E8-4997-B0BB-BFACC75B9A90 Q28075694-FB988335-7F1E-4036-A04D-7D7FB82C4F3D Q28729025-E0D170FE-8901-411F-B05D-F0A7BBFE6FDC Q30010165-C86A8267-459A-42D7-A2B4-9156665F50C8 Q30570557-377891FA-F5E0-4819-987A-0E3306F6C09C Q33622771-9B6C8718-77C5-4A33-A008-955B8B07FC49 Q33644248-1C08106C-7A6C-4BD1-A031-F6B7DC546C95 Q33660210-666D325F-4FC3-425A-9424-D455CBABF9D0 Q33676630-D933B8BE-F252-40A6-A0B2-80698B878A78 Q35088292-9324F608-DD35-46CD-A208-1483B06B97BE Q35196505-9E828107-DEE7-406B-AE81-57AF2EE120FD Q36081148-811641E9-89FF-4BCB-A778-4A078DB211E6 Q36111190-35BAD508-89F5-4A88-97C7-1425934BC149 Q36276462-7991C3D3-AFF1-4975-8B9F-5492563AE902 Q36281845-4EBBEECD-765A-4277-941C-440A40435CDB Q36727960-B987DE42-78E9-48B4-AA0F-9DD64A98928D Q36815449-AD32C8E5-FC94-4892-894B-21ECAB85C01D Q36906028-DE5E4FBF-896A-4F2B-9D1D-A2BC5175EB9B Q36915933-68435EAD-3A94-4377-B34E-328126AD79C6 Q37012536-0613F323-7B3F-4ABE-91CB-DC00DA38E0EB Q37024994-EC33782D-5E44-4722-BB55-2132681AAF2A Q37099969-6219130D-0B40-40B9-A0CB-9FA946065238 Q37270321-05977DF1-B0B8-4D16-89E6-EE584FF48CCD Q37272336-B6B86D20-0D57-466E-B78B-3F13C25D8478 Q37300442-B8F55D58-D6DB-4312-8955-9E99304ED4D2 Q37891583-FDF1F23B-1333-46A4-923E-2EDD545DE0B0 Q37971469-5E56C7D0-84EC-496F-A405-D2E03F9C5FBD Q38204313-52095887-181B-4647-AE53-A81537DD578F Q38636019-CE850039-C1C3-4E2D-A8A5-1C55D0BB55F1 Q38660421-EA07943A-F4F8-4B52-AC11-CA392A09ABD1 Q38753852-DAED0524-970E-4C14-AC13-8CB933A4AF61 Q38957969-5BDBD6A1-FC42-4868-91FF-C1C12195E96D Q39079514-28560520-580E-4DA6-A964-894B8FF50244 Q39106572-1E30CB0E-0681-46F0-97CA-FB3FB0FCE5C9 Q39224160-C9F31BE3-FE8E-467C-B98F-C89131A91701 Q40240401-73704340-9F10-4EB7-BAA1-FDF1F7C23154 Q40532007-0348FF26-3CBF-4B6E-8C91-8C04D9451D94 Q41451997-51E1EF81-BE0E-4508-81F6-994A9D347004

P2860

Antiretroviral therapy in macrophages: implication for HIV eradication.

http://www.wikidata.org/entity/Q34298792

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Antiretroviral therapy in macrophages: implication for HIV eradication.

@ast

Antiretroviral therapy in macrophages: implication for HIV eradication.

@en

Antiretroviral therapy in macrophages: implication for HIV eradication.

@nl

type

label

Antiretroviral therapy in macrophages: implication for HIV eradication.

@ast

Antiretroviral therapy in macrophages: implication for HIV eradication.

@en

Antiretroviral therapy in macrophages: implication for HIV eradication.

@nl

prefLabel

Antiretroviral therapy in macrophages: implication for HIV eradication.

@ast

Antiretroviral therapy in macrophages: implication for HIV eradication.

@en

Antiretroviral therapy in macrophages: implication for HIV eradication.

@nl

P1433

Q34298792-5EDFD596-4CE4-44F3-8181-6C503CAA5D90

P1476

Q34298792-491B93DF-FC8D-4F2E-9995-2EBFC35E6610

P2093

Q34298792-75AEBDD5-20B3-499C-91F6-108CC8C9FC72

P2860

Q34298792-02CDA870-8739-4A31-BB54-48740842E310

Q34298792-038C0FFF-74D2-4969-A323-6403A6D8EBD1

Q34298792-04B19298-0CF4-4281-ABBB-24E2499A6668

Q34298792-083DF066-777D-48FA-A15E-55AE1D329588

Q34298792-0D33DDDD-55B1-4F09-9D90-DCE751811402

Q34298792-12344814-0B6C-46C4-AA3F-4387CFE38D62

Q34298792-13F164F0-5A62-47B8-BA38-612D2A57BF95

Q34298792-1813A4C5-F78F-4C8E-B76C-E63799DE8A49

Q34298792-19B9C59C-3C98-4FD5-8414-7443EEFBCC24

Q34298792-19F3B990-8204-4C72-BCDF-375030D6B87B

P304

Q34298792-D9A341B2-BB07-49E4-9991-92F3D43132B6

P31

Q34298792-C5C45A1A-2938-41B5-91DE-47D1CAE1398A

P356

Q34298792-7179BCAB-0982-4A8A-86DF-EFFE7F299338

P433

Q34298792-DB7A3EDB-1EDF-44D1-9DDC-FA12D0CF7B24

P478

Q34298792-642D21E8-338E-41C4-B0DF-19A093C7E8C1

P50

Q34298792-856AED6C-F4A1-407C-8D88-FDCEE7D832A7

P577

Q34298792-E1BC0B6A-3E20-43D6-9883-972EE8F763F4

P698

Q34298792-8138FAC2-D2AD-4F97-910B-9E5D5DF71225

P921

Q34298792-2FF2A04D-C424-47E8-8DFA-EF1BF2ED4028

Q34298792-863EC68F-0DAC-4F44-A924-CBF71C8B8B40

Q34298792-9A1F22B4-CADF-421F-B0D6-270B8B743245

Q34298792-E0F80BF6-58EC-41A6-8762-DC8EF8A82992

P932

Q34298792-3C7815D7-5F45-4CFB-ADDA-7715B0C3AABD

P356

P1433

Antiviral Chemistry & Chemotherapy

P1476

Antiretroviral therapy in macrophages: implication for HIV eradication.

@en

P2093

Christina Gavegnano

http://www.w3.org/2001/XMLSchema#string

P2860

TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression

Akt inhibitors as an HIV-1 infected macrophage-specific anti-viral therapy

M-1/M-2 macrophages and the Th1/Th2 paradigm

Functional expression of the multidrug resistance protein 1 in microglia

Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression

Macrophage activation and polarization

The role of mononuclear phagocytes in HTLV-III/LAV infection

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

Reviving protease inhibitors: new data and more options.

Scientific rationale for antiretroviral therapy in 2005: viral reservoirs and resistance evolution.

P304

63-78

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3851/IMP1374

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Raymond F. Schinazi

P577

2009-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19843977

http://www.w3.org/2001/XMLSchema#string

P921

eradication of infectious diseases

antiretroviral drug

P932

2978531

http://www.w3.org/2001/XMLSchema#string